BACKGROUND: Pancreatic fistula is a potentially life-threatening complication after a pancreatic resection. The aim of this systematic review was to evaluate the role of matrix-bound sealants after a pancreatic resection in terms of preventing or ameliorating the course of a post-operative pancreatic fistula. METHODS: A systematic search was performed in the literature from May 2005 to April 2015. Included were clinical studies using matrix-bound sealants after a pancreatic resection, reporting a post-operative pancreatic fistula (POPF) according to the International Study Group on Pancreatic Fistula classification, in which grade B and C fistulae were considered clinically relevant. RESULTS: Two were studies on patients undergoing pancreatoduodenectomy (sealants n = 67, controls n = 27) and four studies on a distal pancreatectomy (sealants n = 258, controls n = 178). After a pancreatoduodenectomy, 13% of patients treated with sealants versus 11% of patients without sealants developed a POPF (P = 0.76), of which 4% versus 4% were clinically relevant (P = 0.87). After a distal pancreatectomy, 42% of patients treated with sealants versus 52% of patients without sealants developed a POPF (P = 0.03). Of these, 9% versus 12% were clinically relevant (P = 0.19). CONCLUSIONS: The present data do not support the routine use of matrix-bound sealants after a pancreatic resection, as there was no effect on clinically relevant POPF. Larger, well-designed studies are needed to determine the efficacy of sealants in preventing POPF after a pancreatoduodenectomy.
BACKGROUND:Pancreatic fistula is a potentially life-threatening complication after a pancreatic resection. The aim of this systematic review was to evaluate the role of matrix-bound sealants after a pancreatic resection in terms of preventing or ameliorating the course of a post-operative pancreatic fistula. METHODS: A systematic search was performed in the literature from May 2005 to April 2015. Included were clinical studies using matrix-bound sealants after a pancreatic resection, reporting a post-operative pancreatic fistula (POPF) according to the International Study Group on Pancreatic Fistula classification, in which grade B and C fistulae were considered clinically relevant. RESULTS: Two were studies on patients undergoing pancreatoduodenectomy (sealants n = 67, controls n = 27) and four studies on a distal pancreatectomy (sealants n = 258, controls n = 178). After a pancreatoduodenectomy, 13% of patients treated with sealants versus 11% of patients without sealants developed a POPF (P = 0.76), of which 4% versus 4% were clinically relevant (P = 0.87). After a distal pancreatectomy, 42% of patients treated with sealants versus 52% of patients without sealants developed a POPF (P = 0.03). Of these, 9% versus 12% were clinically relevant (P = 0.19). CONCLUSIONS: The present data do not support the routine use of matrix-bound sealants after a pancreatic resection, as there was no effect on clinically relevant POPF. Larger, well-designed studies are needed to determine the efficacy of sealants in preventing POPF after a pancreatoduodenectomy.
Authors: Gabriel Mihai Marta; Francesco Facciolo; Lars Ladegaard; Hendrik Dienemann; Attila Csekeo; Federico Rea; Sebastian Dango; Lorenzo Spaggiari; Vilhelm Tetens; Walter Klepetko Journal: Eur J Cardiothorac Surg Date: 2010-06-11 Impact factor: 4.191
Authors: Julie Hallet; Francis S W Zih; Raymond G Deobald; Adena S Scheer; Calvin H L Law; Natalie G Coburn; Paul J Karanicolas Journal: HPB (Oxford) Date: 2014-07-07 Impact factor: 3.647
Authors: C Kristian Enestvedt; Brian S Diggs; Maria A Cassera; Chet Hammill; Paul D Hansen; Ronald F Wolf Journal: Am J Surg Date: 2012-03-29 Impact factor: 2.565
Authors: Ulrich Adam; Frank Makowiec; Hartwig Riediger; Wolfgang D Schareck; Stefan Benz; Ulrich T Hopt Journal: Am J Surg Date: 2004-02 Impact factor: 2.565
Authors: M Schindl; R Függer; P Götzinger; F Längle; M Zitt; S Stättner; P Kornprat; K Sahora; D Hlauschek; M Gnant Journal: Br J Surg Date: 2018-04-17 Impact factor: 6.939
Authors: F Jasmijn Smits; Anne Claire Henry; Casper H van Eijck; Marc G Besselink; Olivier R Busch; Mark Arntz; Thomas L Bollen; Otto M van Delden; Daniel van den Heuvel; Christiaan van der Leij; Krijn P van Lienden; Adriaan Moelker; Bert A Bonsing; Inne H M Borel Rinkes; Koop Bosscha; R M van Dam; Sebastiaan Festen; B Groot Koerkamp; Erwin van der Harst; Ignace H de Hingh; Geert Kazemier; Mike Liem; B Marion van der Kolk; Vincent E de Meijer; Gijs A Patijn; Daphne Roos; Jennifer M Schreinemakers; Fennie Wit; C Henri van Werkhoven; I Quintus Molenaar; Hjalmar C van Santvoort Journal: Trials Date: 2020-05-07 Impact factor: 2.279